N/A

N/A

Rafael Velázquez-Cruz completed a degree in Biological Pharmaceutical Chemistry at the Metropolitan Autonomous University. He obtained a Master’s degree in Molecular Biomedicine from the National Polytechnic Institute, a Doctorate in Biomedical Sciences from the Faculty of Medicine at the National Autonomous University of Mexico and a postdoctoral degree from the Department of Genetics, Microbiology and Statistics of the Faculty of Biology at the University of Barcelona. He is currently a Researcher in Medical Sciences “D”, assigned to the Bone Metabolism Genomics laboratory of INMEGEN and a member of the National System of Researchers (SNI) Level II. In 2005, he started own projects or collaborations on the following research topics: Genomics of autoimmune diseases, Genomics of Liver Diseases, Genomics of metabolic diseases, Genomics of Bone metabolism, Genomics of the Microbiome and Proteomics, encompassing studies on biomarker and risk marker genetics. This research has led to important contributions, such as the identification of microRNAs as potential biomarkers and as a support tool in the diagnosis of osteosarcoma and osteoporosis. In addition, his research group is a pioneer in the identification of the genetic factors involved in osteoporosis in the Mexican population. Many of the results from these studies were published in high-impact journals, such as Journal of Bone and Mineral Research, Annals of Rheumatic Diseases and PLoS One.

N/A

Dr. Jorge Salmerón is a full-time professor at the Center for Research in Policies, Population, and Health, Faculty of Medicine, National Autonomous University of Mexico. He holds a Doctorate in Epidemiology Sciences at INSP. His research interests include the influence of diet on carbohydrate metabolism, particularly the impact of certain dietary patterns on the risk of developing diabetes mellitus, to achieve a better understanding of the epidemiology of diabetes and provide helpful information for the design and planning of health policies aimed at controlling the problem of diabetes in our country.